Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00933595 · ClinicalTrials.gov registry record · NA
Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)
A NA study of HIV Infections and Pulmonary Complications, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00933595: Completed NA study of HIV Infections and Pulmonary Complications, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00933595 is a NA study of HIV Infections and Pulmonary Complications that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00933595, a NA study of HIV Infections and Pulmonary Complications, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
The Lung HIV goal is to facilitate the data and specimen collection efforts of eight individual HIV and pulmonary studies that operate under the direction of the NHLBI. The Lung HIV study will build on existing studies to facilitate the start-up of new projects to further the understanding of the relationship between pulmonary disease and HIV infection. There is only one clinical trial being performed in this network at Ohio State University and it will be reported here.
Conditions Studied
Interventions
- OTHER Smoking Cessation
Study Locations (1)
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-09 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT00933595 record still lists
NCT00933595 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Smoking Cessation is the first listed.
NCT00933595 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00933595 about?
NCT00933595 is a clinical study titled "Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)". The Lung HIV goal is to facilitate the data and specimen collection efforts of eight individual HIV and pulmonary studies that operate under the direction of the NHLBI. The Lung HIV study will build on existing studies to facilitate the start-up of new projects to further the understanding of the re...
What is the current status of trial NCT00933595?
This trial is currently completed. It is a NA study. The study started on 2007-09. Estimated completion is 2013-11.
What conditions does trial NCT00933595 study?
This clinical trial studies the following conditions: HIV Infections, Pulmonary Complications.
What interventions are being tested in trial NCT00933595?
The interventions under investigation include: Smoking Cessation (OTHER).
Who is sponsoring clinical trial NCT00933595?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00933595 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia